Mylan to Buy Abbott’s Generic Drug Business Outside U.S. for $5.3 Billion – NYTimes.com

Sent by globalcrossroadscapital.com: Mylan to Buy Abbott’s Generic Drug Business Outside U.S. for $5.3 Billion – NYTimes.com By CHAD BRAY Mylan would combine Abbott?s generic drug operations in Europe, Japan, Canada, Australia and New Zealand with its existing operations and reincorporate in the Netherlands in an inversion. Or, copy and paste this URL into your …

Read more »